User profiles for S.K. Mahil
 | Satveer MahilSt John's Institute of Dermatology, King's College London and Guy's and St Thomas' … Verified email at kcl.ac.uk Cited by 3100 |
[HTML][HTML] Psoriasis: a brief overview
Psoriasis is a clinically heterogeneous lifelong skin disease that presents in multiple forms
such as plaque, flexural, guttate, pustular or erythrodermic. An estimated 60 million people …
such as plaque, flexural, guttate, pustular or erythrodermic. An estimated 60 million people …
[HTML][HTML] Update on psoriasis immunopathogenesis and targeted immunotherapy
Over recent years, significant progress has been made in characterisation of the underlying
pathogenic mechanisms in psoriasis, a common cutaneous disease that is associated with …
pathogenic mechanisms in psoriasis, a common cutaneous disease that is associated with …
Genetics of psoriasis
Substantial progress has been made into identifying the genetic determinants of common
immune-mediated diseases. This has highlighted biologic pathways involved in disease …
immune-mediated diseases. This has highlighted biologic pathways involved in disease …
[HTML][HTML] The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
Background Patients on therapeutic immunosuppressants for immune-mediated inflammatory
diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate …
diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate …
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
… Mahil PhD, MRCP a ∗ , Nick Dand PhD b c ∗ , Kayleigh J. Mason PhD d , Zenas ZN Yiu
PhD, MRCP d , Teresa Tsakok MRCP a , Freya Meynell MSc a , Bola Coker MSc e , Helen …
PhD, MRCP d , Teresa Tsakok MRCP a , Freya Meynell MSc a , Bola Coker MSc e , Helen …
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update
…, W Edwards, E MacMahon, SK Mahil… - British Journal of …, 2020 - academic.oup.com
… SK Mahil , SK Mahil … MacMahon, SK Mahil, A. McGuire, R. Murphy, C. …
Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …
because of their ability to ameliorate shared immune pathways across immune-mediated …
[HTML][HTML] Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a …
Background COVID-19 vaccines have robust immunogenicity in the general population.
However, data for individuals with immune-mediated inflammatory diseases who are taking …
However, data for individuals with immune-mediated inflammatory diseases who are taking …
[HTML][HTML] AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production
Prominent skin involvement is a defining characteristic of autoinflammatory disorders caused
by abnormal IL-1 signaling. However, the pathways and cell types that drive cutaneous …
by abnormal IL-1 signaling. However, the pathways and cell types that drive cutaneous …
An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target
Interleukin (IL)–36α, IL-36β, and IL-36γ are innate mediators of acute epithelial inflammation.
We sought to demonstrate that these cytokines are also required for the pathogenesis of …
We sought to demonstrate that these cytokines are also required for the pathogenesis of …